Overview

YF476 in Barrett's Esophagus

Status:
Completed
Trial end date:
2017-12-27
Target enrollment:
Participant gender:
Summary
A phase 2, randomised, double-blind, out-patient trial to determine if YF476 is a safe and effective treatment in patients with Barrett's esophagus.
Phase:
Phase 2
Details
Lead Sponsor:
Trio Medicines Ltd.
Collaborators:
Columbia University
University of Cambridge
Treatments:
Gastrins